Deva Holding AS | DEVA - 営業経費

金融部門

TRY 78.30

TRY 12.93B

現金と同等

TRY 775.92M

TRY 991.13M

TRY 9.13B

TRY 6.43B

TRY 5.3B

0.18

TRY 820.88M

TRY 882.9M

株当たりのEPS利益

TRY 2.92

自己資本および準備金

TRY 5.79B

売上総利益

TRY 1.32B

債務の支払利息

TRY 272.53M

TRY 559.97M

TRY 15.66B

当期純利益

TRY 583.98M

TRY 1.35B

TRY 964.87M

普通株資本

TRY 200.02M

収益へのPE価格

6.55

TRY 2.32B

販売および管理費

TRY 462.26M

貿易債権者

TRY 809.81M

貿易債務者

TRY 3.03B

	営業経費	変化する		日付
Akebia Therapeutics	USD 63.08M		8.26M	2025-12
Alaunos Therapeutics	USD 952K		60K	2026-06
Avita Medical	AUD 28.56M		534K	2026-06
Deva Holding AS	TRY 1.35B		178.26M	2023-09
Dianthus Therapeutics	USD 62.24M		15.25M	2026-06
Ionis Pharmaceuticals	USD 373M		2.76M	2026-09
IQVIA Holdings	USD 3.82B		2.05B	2026-09
Moderna	USD 1.18B		223M	2026-09
Organon & Co	USD 1.19B		187M	2026-09
Revvity	USD 604.27M		719K	2026-09
Tectonic Therapeutic	USD 24.22M		3.08M	2026-06
Viatris	USD 3.49B		189.1M	2026-09
Xeris Pharmaceuticals	USD 86.93M		11.72M	2026-06